Jan Medina | Investor Relations |
Spiro Rombotis | President and Chief Executive Officer |
Paul McBarron | Executive Vice President, Finance and Chief Operating Officer |
Dr. Judy Chiao | Vice President of Clinical Development and Regulatory Affairs |
Wangzhi Li | Ladenburg Thalmann |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2019 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today’s call, members of the financial community will have an opportunity to ask questions. [Operator Instructions] The company will also be accepting a limited number of questions submitted via e-mail to the address, ir@cyclacel.com. [Operator Instructions] Please note, today’s call is being recorded.